Font Size: a A A
Keyword [Antiplatelet therapy]
Result: 61 - 80 | Page: 4 of 10
61. The Effects Of Triple Antiplatelet Therapy On Inflammation Reaction And Endothelial Function In Patients With Coronary Heart Disease After Interventional Therapy
62. The Efficacy Of Intensive Lipid-lowering Combined With Dual Antiplatelet Therapy In Acute Cerebral Infarction Patients As Well As Its Effects On Blood Lipid And Hypersensitive C-reactive Protein (CRP)
63. Clinical Significance CYP2C19,ABCB1 Gene In Patients With Acute Cononary Syndrome
64. Correlation Analysis Of Cerebral Microbleeds Imaging Score And After Antiplatelet Therapy Cerebral Hemorrhage
65. Application Of The Thrombelastography As A Guidance To Antiplatelet Therapy For ACS Patients Duringthe Perioperative Period Of PCI
66. Clinical Analysis On Risk Factors And Antiplatelet Therapy For Progressive Cerebral Infarction
67. The Clinical Prognosis Of Different Antiplatelet Therapy In Patients With Acute Coronary Syndrome During Perioperative Of Percutaneous Coronary Intervention
68. The Safety Of Ticagrelor For Long Term Antiplatelet Therapy In Patients Undergoing Percutaneous Coronary Intervention
69. Plasma MicroRNAs Predict Major Adverse Cardiovascular Events As Intermediate Biomarkers Of Clopidogrel Antiplatelet Efficacy
70. Effects Of Different Antiplatelet Therapy On Platelet Aggregation Rate And Prognosis In Patients With Acute Cerebral Infarction
71. Efficacy And Safety Of Short-term (≤6 Months) Duration Of Dual Antiplatelet Therapy After Second Generation Drug Eluting Stents:a Meta-Analysis Of Randomized Controlled Trials
72. Recent Progress Of Individualized Antiplatelet Therapy After PCI For Coronary Heart Disease Patients
73. Clinic Value Of Different Antiplatelet Therapy Policies In Preventing And Treating Cardiovascular Events In Elderly Patients With Coronary Heart Disease
74. The Use Status Of Anticoagulation Drugs For Patients With Nonvalvular Atrial Fibrillation In Hospitals Of Chongqing: A Cross-sectional Study
75. The Study On H.Pylori Infection In Patients With Antiplatelet Therapy
76. SC99 Inhibits Platelet Aggregation Via Syk/STAT3/PLCγ2 Signaling Pathway
77. The Effect Estimate Of Antiplatelet Agents Plus Statins Therapy On The Recurrence And Progress Of TIA/Minor Stroke During Hospitalization
78. The Significance Of Thrombelastography For Guiding Antiplatelet Therapy In Patients After PCI
79. Comparisons Of Prevention For PCI Related Periprocedural Myocardial Infarction Attributed To Loading Dose Of Ticagrelor Versus Clopidogrel
80. The Analysis Of Risk Factors And The Outcomes Of Dual Antiplatelet Therapy On The CISS Type Of Acute Minor Stroke
  <<First  <Prev  Next>  Last>>  Jump to